
Heidelberg, Germany, May 15, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical ...

Peer-reviewed article published in Journal of Pharmaceutical Science evaluates skin tolerability and bioavailability of ...
Click to continue to site. Closing